Fencamfamin

Fencamfamin is a stimulant which was developed in the 1960s and used for the treatment of obesity. Fencamfamin is produced by reacting 3-phenylpropanol with cyanogen bromide and ammonia.

Pharmacology

Fencamfamin acts as an indirect dopamine agonist. It releases monoamines from the body, but the exact mechanism of action is not fully understood. It is thought to inhibit the reuptake of dopamine and norepinephrine, thereby increasing the levels of these neurotransmitters in the brain.

Medical Uses

Fencamfamin was primarily used as an appetite suppressant in the treatment of obesity. It was also used off-label for the treatment of narcolepsy and attention deficit hyperactivity disorder (ADHD).

Side Effects

The side effects of fencamfamin can include insomnia, nervousness, and hyperactivity. In rare cases, it can cause psychosis and hallucinations. Long-term use can lead to dependence and withdrawal symptoms.

Legal Status

Fencamfamin is a controlled substance in many countries due to its potential for abuse and addiction. In the United States, it is classified as a Schedule III controlled substance under the Controlled Substances Act.

See Also

• Amphetamine
• Methylphenidate
• Phentermine

Fencamfamin Resources
Latest articles Most recent articles Ongoing trials	Wikipedia